Monday, October 12, 2015

Lilly to Halt Cholesterol-Drug Development

Eli Lilly is ending development of its experimental cholesterol-modifying drug for cardiovascular disease because the treatment wasn’t effective enough in a clinical trial.

from WSJ.com: US Business http://ift.tt/1R7jn2M
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)